Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis

<div>Computed tomography (CT) images (a) before and (b) after 3 administrations of atezolizumab showing a significant decrease in the size of lymph nodal metastasis.</div>

Case Reports in Oncological Medicine

fig2

Figure 2

Figure 2: Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis 

Figure 2 | Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis 